NCIt definition : An orally bioavailable indole ether quinazoline derivative and vascular endothelial
growth factor receptor (VEGFR) inhibitor, with potential antineoplastic activity.
Upon oral administration, cediranib binds to and inhibits the three VEGFR subtypes
1 (VEGFR-1), 2 (VEGFR-2) and 3 (VEGFR-3), thereby blocking VEGF-signaling, angiogenesis,
and tumor cell growth. Expression of VEGFRs may be upregulated in a variety of tumor
cell types.;
UNII : NQU9IPY4K9;
InChIKey : XXJWYDDUDKYVKI-UHFFFAOYSA-N;
CAS number : 288383-20-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 288383-20-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;